Affimed and NKGen Biotech Announce Initiation of Patient Recruitment in a First-in-human Phase 1/2a Trial of Innate Cell Engager AFM24 in Combination with Autologous NK Cell Product SNK01
November 8, 2021
November 8, 2021
November 4, 2021
November 4, 2021
October 29, 2021
October 1, 2021
September 8, 2021
August 26, 2021
August 26, 2021
August 23, 2021
July 30, 2021